2017
DOI: 10.1080/14636778.2017.1354692
|View full text |Cite
|
Sign up to set email alerts
|

A market in the making: the past, present and future of direct-to-consumer genomics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
22
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
2
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 40 publications
(22 citation statements)
references
References 43 publications
0
22
0
Order By: Relevance
“…As genotyping costs have fallen over the last decade, direct-to-consumer (DTC) genetic testing (Hogarth et al, 2008; Hogarth and Saukko, 2017; Khan and Mittelman, 2018) has become a major industry, with over 26 million people enrolled in the databases of the five largest companies (Regalado, 2019). One of the major applications of DTC genetics has been genetic genealogy.…”
Section: Introductionmentioning
confidence: 99%
“…As genotyping costs have fallen over the last decade, direct-to-consumer (DTC) genetic testing (Hogarth et al, 2008; Hogarth and Saukko, 2017; Khan and Mittelman, 2018) has become a major industry, with over 26 million people enrolled in the databases of the five largest companies (Regalado, 2019). One of the major applications of DTC genetics has been genetic genealogy.…”
Section: Introductionmentioning
confidence: 99%
“…Since the mid-2000s, companies have been marketing various forms of personal genomic (DNA) testing to the public, typically online [ 1 ]. Termed by experts as direct-to-consumer genetic tests, they are marketed for a variety of purposes, offering a spectrum of information to consumers.…”
Section: Introductionmentioning
confidence: 99%
“…Numerous concerns about the concept of DTC-GT have been debated in the literature and by regulators (Covolo et al 2015;Hall et al 2017), including, among others, lack of medical supervision and genetic counseling, inadequate informed consent, questionable analytic and clinical validity, risks of misdiagnosis and overdiagnosis, negative impacts on family members, and on public health (Badalato, Kalokairinou, and Borry 2017;Hogarth and Saukko 2017). As a consequence, DTC-GT has given rise to regulatory attempts at limiting the availability of such services (Borry, Cornel, and Howard 2010;Borry et al 2012;Curnutte and Testa 2012).…”
mentioning
confidence: 99%